icon.article.dark Industry news In vitro and in vivo blood brain barrier assay for neurological diseases Recently, Creative Bioarray announced the release of blood brain barrier assay to develop drugs in order to treat neurological diseases. As an active interface between the circulation and the central nervous system (CNS), BBB strictly controls the molecular and cellular Read more icon.arrow--dark
